Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Bolt Biotherapeutics (BOLT) Other Operating Expenses (2024)

Bolt Biotherapeutics' Other Operating Expenses history spans 1 years, with the latest figure at $1.5 million for Q4 2024.

  • For Q4 2024, Other Operating Expenses changed N/A year-over-year to $1.5 million; the TTM value through Sep 2025 reached $1.5 million, changed N/A, while the annual FY2024 figure was $1.5 million, N/A changed from the prior year.
  • Other Operating Expenses for Q4 2024 was $1.5 million at Bolt Biotherapeutics.
  • Across five years, Other Operating Expenses topped out at $1.5 million in Q4 2024 and bottomed at $1.5 million in Q4 2024.